Filipa V. Oliveira

Filipa V. Oliveira

Auto-generated profile, based on publicly available information

Filipa V. Oliveira

Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2026 in Nature
Verified
Journal Article
Open access
PDF file
IGIrene Garcia-Gonzalez
Irene Garcia-Gonzalez
SRSusana F. Rocha
Susana F. Rocha
FOFilipa V. Oliveira
Filipa V. Oliveira
MSMaria S. Sanchez-Muñoz
Maria S. Sanchez-Muñoz
MLMariya Lytvyn
Mariya Lytvyn
RBRui Benedito
Rui Benedito
The vascular endothelial growth factor (VEGF) ligand and its main receptor VEGFR2 are considered to be essential for endothelial differentiation, proliferation, sprouting and survival 1 . Blood vessels cannot form in growing embryos or tissues when VEGF–VEGFR2 signalling is compromised in all cells 2,3 . The anti-VEGF antibody, which can block angiogenesis in cancer, wound healing or ischaemic diseases, is among the most widely used antibodies in the clinic. However, vascular resistance to anti-VEGF therapy has been reported 4,5 . Here we used iFlpMosaics and iSuRe –HadCre to induce and track genetic mosaics of endothelial cells (ECs) lacking VEGFR2 during the entire embryonic and postnatal development. These Vegfr2 -knockout ( Vegfr2 KO ) ECs adapted, proliferated normally and competed with wild-type cells over time, eventually forming a substantial portion of the vascular network in most organs. Vegfr2 KO ECs could not sprout during the first wave of angiogenesis in most tissues, because this process is highly VEGF-dependent and favours growth and mobilization of wild-type ECs. However, owing to their inability to respond to VEGF, Vegfr2 KO ECs became dominant in veins, which represented a long-term and continuous source of ECs for subsequent waves of VEGF-independent angiogenesis. Comparative single-cell RNA sequencing analysis of ECs with acute and long-term loss of VEGFR2 identified both common and organ-specific molecular mechanisms of adaptation and resistance to VEGF signalling loss. These included significant endothelial venousization and upregulation of ligands for VEGFR1 and VEGFR3. VEGFR1 only partially compensated for VEGFR2 loss in capillary ECs, whereas VEGFR3 compensated only in arterial ECs. Loss of the three VEGF receptors did not compromise venous growth. Notably, loss of the master regulator of venous development, NR2F2 (also known as COUP-TFII), significantly compromised expansion of Vegfr2 KO ECs. This work has implications for our understanding of the role of VEGF receptors in angiogenesis and demonstrates venousization as a mechanism of adaptation and resistance to VEGF signalling loss during angiogenesis.